Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Matrix completes enrollment in IntraDose trials

Sep. 16, 1998

Corixa's MUC-1 vaccine technology receives patent protection

Sep. 16, 1998

Hycamtin receives first approval for small cell lung cancer in Switzerland

Sep. 15, 1998

Onyx discovers another therapeutic virus for cancer therapy

Sep. 15, 1998

Antigestagenic steroid esters patented by Schering AG

Sep. 15, 1998

rAd/p21: an effective gene therapy approach for treating lung cancer

Sep. 15, 1998

Japanese researchers report progress in the gene therapy of gastric cancer

Sep. 14, 1998

FDA recommends full approval of first new treatment for metastatic colorectal cancer in 40 years

Sep. 11, 1998

DDE-131: new apoptosis-inducing antitumor agent from WHI

Sep. 11, 1998

Natural nonpeptide inhibitors of protein farnesyltransferase discovered at Merck & Co.

Sep. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...